EUVIMEDEUVIMED entdecken
Open Access

[ 18 F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF -Targeted Therapy

Samir A Dagher iD, Kim O Learned iD, Richard Dagher iD, Jennifer Rui Wang, Xiao Zhao, S Mohsen Hosseini, Anastasios Maniakas, Maria E Cabanillas iD, Naifa L Busaidy, Ramona Dadu, Priyanka Iyer, Mark E Zafereo iD und 1 weitere

American Journal of Neuroradiology · 2025

DOI: 10.3174/ajnr.a8588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2025. Verfasst von Samir A Dagher und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Thyroid NeoplasmsThyroid Carcinoma, AnaplasticPositron Emission Tomography Computed TomographyProto-Oncogene Proteins B-rafHumansMaleFemaleRetrospective StudiesAgedMiddle AgedRadiopharmaceuticalsNeoplasm, ResidualAged, 80 and overAdult

Substanzen

Fluorodeoxyglucose F18Proto-Oncogene Proteins B-rafRadiopharmaceuticalsBRAF protein, human

Autor:innen und Institutionen

  • From the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Head and Neck Surgery (J.R.W., X.Z., A.M., M.E.Z.), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Pathology (S.M.H.), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Endocrine Neoplasia and Hormonal Disorders (M.E.C., N.L.B., R.D., P.I.), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • From the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas AKhalaf@mdanderson.org.

ORCID-Profile: Samir A Dagher, Kim O Learned, Richard Dagher, Maria E Cabanillas, Mark E Zafereo, Alexander M Khalaf

Zitieren

APA

Dagher, S. A., Learned, K. O., Dagher, R., Wang, J. R., Zhao, X., Hosseini, S. M., Maniakas, A., Cabanillas, M. E., Busaidy, N. L., Dadu, R., Iyer, P., Zafereo, M. E., & Khalaf, A. M. (2025). [ 18 F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF -Targeted Therapy. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8588

Vancouver

Dagher SA, Learned KO, Dagher R, Wang JR, Zhao X, Hosseini SM, et al. [ 18 F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF -Targeted Therapy. American Journal of Neuroradiology. 2025. doi:10.3174/ajnr.a8588

BibTeX
@article{Dagher2025,
  author = {Dagher, Samir A and Learned, Kim O and Dagher, Richard and Wang, Jennifer Rui and Zhao, Xiao and Hosseini, S Mohsen and Maniakas, Anastasios and Cabanillas, Maria E and Busaidy, Naifa L and Dadu, Ramona and Iyer, Priyanka and Zafereo, Mark E and Khalaf, Alexander M},
  title = {[ 18 F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF -Targeted Therapy},
  journal = {American Journal of Neuroradiology},
  year = {2025},
  doi = {10.3174/ajnr.a8588}
}
Kostenlos starten →